Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: VidaMed

This article was originally published in The Gray Sheet

Executive Summary

VidaMed: Board of directors seeking replacement for Stuart Edwards, current CEO, president and founder of the Menlo Park, California-based firm. A committee including three top-level VidaMed execs -- Chairman David Douglass and board members Pierre Lamond and Lawrence Mohr -- is conducting a search for a successor to Edwards, who will remain a member of the firm's board of directors. VidaMed says it is making the change in preparation for premarket approval of its TUNA transurethral needle ablation radiofrequency system for treatment of benign prostatic hyperplasia, which the firm expects to receive in 1996...
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT005336

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel